Variant report
Variant | rs2607258 |
---|---|
Chromosome Location | chr19:51972427-51972428 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr19:51971107-51973140 | K562 | blood: | n/a | n/a |
2 | POLR2A | chr19:51970702-51973376 | K562 | blood: | n/a | n/a |
3 | MAX | chr19:51972333-51972868 | K562 | blood: | n/a | chr19:51972711-51972720 |
4 | HEY1 | chr19:51971106-51972839 | K562 | blood: | n/a | n/a |
5 | POLR2A | chr19:51970738-51973354 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr19:51971132-51973240 | K562 | blood: | n/a | n/a |
7 | TBP | chr19:51972065-51972760 | K562 | blood: | n/a | n/a |
8 | UBTF | chr19:51971094-51973051 | K562 | blood: | n/a | n/a |
9 | MYC | chr19:51971178-51973064 | K562 | blood: | n/a | chr19:51972711-51972720 |
10 | TBL1XR1 | chr19:51970726-51973188 | K562 | blood: | n/a | n/a |
11 | ZC3H11A | chr19:51972234-51972647 | K562 | blood: | n/a | n/a |
12 | MAX | chr19:51972199-51972965 | K562 | blood: | n/a | chr19:51972711-51972720 |
13 | EP300 | chr19:51969868-51973060 | K562 | blood: | n/a | n/a |
14 | RCOR1 | chr19:51971137-51973169 | K562 | blood: | n/a | n/a |
15 | ZNF143 | chr19:51971861-51972523 | K562 | blood: | n/a | chr19:51972044-51972062 chr19:51972400-51972419 chr19:51972317-51972332 |
16 | POLR2A | chr19:51971124-51973390 | K562 | blood: | n/a | n/a |
17 | ARID3A | chr19:51972311-51972737 | K562 | blood: | n/a | n/a |
18 | ZBTB7A | chr19:51972409-51972680 | K562 | blood: | n/a | n/a |
19 | MYC | chr19:51971214-51973105 | K562 | blood: | n/a | chr19:51972711-51972720 |
20 | POLR2A | chr19:51971138-51973221 | K562 | blood: | n/a | n/a |
21 | IRF1 | chr19:51969267-51973066 | K562 | blood: | n/a | chr19:51972064-51972078 chr19:51971883-51971892 chr19:51971396-51971405 |
22 | SIN3AK20 | chr19:51972414-51972835 | K562 | blood: | n/a | n/a |
23 | IRF1 | chr19:51970753-51973090 | K562 | blood: | n/a | chr19:51972064-51972078 chr19:51971883-51971892 chr19:51971396-51971405 |
24 | POLR2A | chr19:51971152-51973062 | K562 | blood: | n/a | n/a |
25 | MAZ | chr19:51971134-51972759 | K562 | blood: | n/a | chr19:51972711-51972720 |
26 | MAX | chr19:51972249-51973069 | K562 | blood: | n/a | chr19:51972711-51972720 |
27 | MAX | chr19:51971267-51972906 | NB4 | blood: | n/a | chr19:51972711-51972720 |
28 | JUN | chr19:51972088-51972680 | K562 | blood: | n/a | n/a |
29 | POLR2A | chr19:51971580-51973267 | K562 | blood: | n/a | n/a |
30 | TEAD4 | chr19:51970779-51973013 | K562 | blood: | n/a | n/a |
31 | MYC | chr19:51971216-51972932 | K562 | blood: | n/a | chr19:51972711-51972720 |
32 | HMGN3 | chr19:51972300-51972478 | K562 | blood: | n/a | n/a |
33 | JUND | chr19:51970783-51972768 | K562 | blood: | n/a | chr19:51971884-51971892 |
34 | POLR2A | chr19:51971104-51972639 | K562 | blood: | n/a | n/a |
35 | POLR2A | chr19:51971096-51973184 | K562 | blood: | n/a | n/a |
36 | E2F6 | chr19:51972382-51972821 | K562 | blood: | n/a | n/a |
37 | POLR2A | chr19:51972255-51973359 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SIGLEC26P | TF binding region |
ENSG00000213822 | Chromatin interaction |
ENSG00000269181 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10424482 | 0.87[EUR][1000 genomes] |
rs10424572 | 0.98[EUR][1000 genomes] |
rs10424783 | 1.00[CEU][hapmap];0.87[EUR][1000 genomes] |
rs10424804 | 1.00[CEU][hapmap];0.92[GIH][hapmap];0.91[TSI][hapmap];0.87[EUR][1000 genomes] |
rs11878257 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11878282 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11878388 | 1.00[CEU][hapmap];0.98[EUR][1000 genomes] |
rs11881105 | 0.94[EUR][1000 genomes] |
rs16982729 | 1.00[CEU][hapmap];0.89[YRI][hapmap];0.89[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs17206902 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs185254 | 0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs2607257 | 1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2607259 | 1.00[CEU][hapmap];1.00[GIH][hapmap];0.87[LWK][hapmap];1.00[TSI][hapmap];0.81[YRI][hapmap];0.81[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2607260 | 0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs28539101 | 1.00[EUR][1000 genomes] |
rs28607420 | 0.87[EUR][1000 genomes] |
rs2864090 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2864091 | 1.00[EUR][1000 genomes] |
rs2864092 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.94[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2864093 | 1.00[CEU][hapmap];0.92[GIH][hapmap];1.00[TSI][hapmap];1.00[EUR][1000 genomes] |
rs36502 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[ASN][1000 genomes] |
rs36503 | 0.81[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs56799568 | 0.98[EUR][1000 genomes] |
rs61201251 | 0.89[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs62115066 | 0.89[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs62116369 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62116370 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62116371 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62116417 | 0.98[EUR][1000 genomes] |
rs62116418 | 0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs62116419 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs62116420 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs62116422 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs7246811 | 0.98[EUR][1000 genomes] |
rs8101777 | 1.00[CEU][hapmap];0.92[GIH][hapmap];0.91[TSI][hapmap];0.87[EUR][1000 genomes] |
rs8107537 | 0.98[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1066308 | chr19:51680133-52103974 | Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 71 gene(s) | inside rSNPs | diseases |
2 | nsv544049 | chr19:51680133-52103974 | Bivalent Enhancer Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 71 gene(s) | inside rSNPs | diseases |
3 | nsv458724 | chr19:51925519-51975723 | Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
4 | nsv579965 | chr19:51925519-51975723 | Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
5 | nsv544051 | chr19:51944903-52147459 | Bivalent Enhancer Strong transcription Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
6 | nsv961163 | chr19:51971394-51976393 | Enhancers Active TSS Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer | TF binding regionChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51964600-51973000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr19:51966800-51973400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr19:51969000-51972600 | Enhancers | Primary hematopoietic stem cells | blood |
4 | chr19:51971800-51973000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr19:51971800-51974200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
6 | chr19:51971800-51975000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr19:51972000-51976000 | Weak transcription | Duodenum Mucosa | Duodenum |
8 | chr19:51972200-51973400 | Flanking Active TSS | K562 | blood |